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The clinical high-risk (CHR) state for psychosis has been established in order to 
prevent the transition to full psychosis; however, demonstrates a high false positive rate 
(Fusar-Poli et al., 2012). Consequently, many CHR individuals may face increased 
labeling and symptom-related stigmatization through accessing early intervention 
services (Yang et al., 2015). As a result, CHR individuals may employ negative coping 
responses (Link et al., 1989) and exhibit increased social preoccupation in order to help 
conceal their mental health status (Link et al., 2015), which may hinder social cognitive 
ability and have lasting impacts on social functioning. This study aimed to delineate 
potential mechanisms by which social cognition, stigma and social functioning are related 
in 173 individuals labeled as CHR. Pearson correlations, mediation and moderated-
mediation analyses were performed. Theory of Mind (ToM) and social relationship 
perception both differentially related to labeling and symptom stigma. Labeling secrecy 
and symptom discrimination mediated the relationship between ToM and social 
functioning and endorsement of a non-psychotic impact status moderated the relationship 
between ToM and labeling discrimination, which may indicate the presence of stigma 
resistance. This study offers a nuanced view of stigma processes as related to social 
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Schizophrenia is a debilitating disorder that carries a large public health burden 
(McGlashan, Walsh, & Woods, 2010). Because of this, there has been a recent shift to 
focus on the risk period before the onset of full-blown psychosis in order to employ early 
identification and intervention strategies to forestall worsening symptoms and improve 
quality of life (Miller et al., 2003). Individuals who experience attenuated psychotic 
symptoms, such as unusual thought content, neurotic and mood-related symptoms, and 
changes in behavior, such as increased social withdrawal, are identified and classified as 
clinical high-risk for psychosis (CHR; Yung & McGorry, 1996; Miller et al., 2003; 
McGlashan, Walsh, & Woods, 2010). These subthreshold psychotic symptoms are 
similar to the hallmark signs of schizophrenia. CHR individuals oftentimes exhibit 
attenuated positive, negative, or disorganized symptoms; however, remain mostly 
insightful to their experiences, meaning they do not endorse full conviction for their 
symptomatology. They typically are able to question how true their symptoms are and 
tend to exhibit reduced belief that their unusual experiences are real as compared to 
individuals with full-blown psychosis (Lappin et al., 2007). These attenuated symptoms 
are commonly assessed by The Structured Interview for Psychosis-Risk Syndromes and 
the Scale of Psychosis-Risk Symptoms (SIPS/SOPS), which includes a structured clinical 
assessment of functioning, family history of psychosis, schizotypal personality disorder 
checklist, and positive, negative, disorganized and general symptoms scored from 1-6. 
Any symptom cluster scored within the 3-5 range indicates attenuation while a score of 6 
demonstrates full psychosis (Miller et al., 2003; McGlashan, Walsh & Woods, 2014).   
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While the SIPS/SOPS has strengthened the field’s ability to accurately predict if a 
person is at-risk for developing a psychotic disorder, research has shown that 
approximately 70-80% of individuals who are identified as CHR will not go on to 
develop psychosis (Fusar-Poli et al., 2012; Ciarleglio et al., 2019). Due to this high false 
positive rate, most individuals who receive psychosis prevention services may be unduly 
exposed to the negative effects of treatment, including stigma associated with the 
initiation of early intervention (Yang et al., 2010; Corcoran, 2016). Because 
schizophrenia-related disorders are among the most highly stigmatized mental health 
conditions (Room et al., 2001), stigma associated with being diagnosed as CHR may 
have significant impacts on self-esteem (Yang et al., 2019; Anglin et al., 2014), which 
may impede social functioning (Lysaker, Roe & Yanos, 2007). Although some 
individuals who undergo this early identification process feel positive emotions 
associated with labeling, such as relief, many also tend to adopt a negative self-view, thus 
deeply affecting identity (Corcoran, 2016).  
Modified Labeling Theory (Link et al., 1989) has been used to conceptualize the 
stigma associated with psychiatric labeling, including in CHR populations (Yang et al., 
2019; Yang et al., 2015; Rusch et al., 2014). This theory posits that as individuals are 
socialized in society, they develop beliefs about how individuals with mental health 
problems are treated by the community, which are often based on negative stereotypes. 
As mental health consumers, individuals may adopt these beliefs (Livingston & Boyd, 
2010) and expect to be discriminated against and devalued based on their mental health 
status (Link et al., 1989). Accordingly, they may employ coping responses such as 
secrecy, withdrawal, and education tactics (i.e., educating others about mental health 
problems, both positively and negatively) based on the level of internalization of these 
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stereotypes, which could have vastly negative consequences for social network ties, 
occupational opportunities, and self-esteem. (Link et al., 1989). Individuals identified as 
CHR may experience discrimination from others or feel shameful about themselves as a 
result of this labeling process, which may lead to increased stigma stress that could 
exacerbate their current symptomatology (Link et al., 1989) and potentially hasten their 
transition to full-blown psychosis (Rusch et al., 2015).  
In addition to experiencing stigma associated with being labeled as CHR (i.e., 
labeling stigma), individuals may also experience stigma associated with psychosis-risk 
symptoms (i.e., symptom stigma). Recent research has shown a differential impact of 
stigma based on labeling processes and symptom experiences in individuals identified as 
CHR (Yang et al., 2015). More specifically, CHR individuals may feel shame associated 
with exhibiting unusual behavior and symptomatology, which could lead to experiences 
of being stigmatized when interacting with others in the community. Thus, at-risk 
populations may confront stigmatizing exchanges that may negatively affect their sense 
of self, which stem from expressing these symptoms within their social circles. 
Therefore, it is crucial to consider both labeling and symptom stigma processes when 
evaluating the experience of individuals identified as CHR.  
 Extending the Modified Labeling Theory (Link et al., 1989), symbolic interaction 
stigma (Link et al., 2015) includes an additional component of anticipated negative 
reactions from others based on personal worry of rejection that is facilitated by the 
discrimination and devaluation process described above, which may occur regardless of 
internalization of stereotypes. Individuals with mental health conditions could not only 
lose social network ties and face structural and personal discrimination from both 
labeling and symptom stigma (Yang et al., 2015; Yang et al., 2019) but also experience 
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an increased cognitive load due to preoccupation with how others might negatively 
evaluate or react to them (Link et al., 2015). This anticipated rejection has been found to 
predict increased instances of social withdrawal in individuals diagnosed with 
schizophrenia-spectrum disorders. Symbolic interaction stigma emphasizes that 
internalization of stigma is not necessary in order for this process to occur; however, it is 
possible that individuals will experience internalized stigma in tandem with this process. 
Thus, individuals identified as CHR may rehearse social interactions or become 
hypervigilant of negative reactions from others (Stryker 1980; Link et al., 2015) as a 
result of experiencing labeling and/or symptom stigma, which could decrease 
performance in social situations (Link et al., 2015; Farina et al., 1971). 
Social cognition is required in order to accurately perceive and effectively 
participate in social interactions. Although there is mixed evidence (Gill et al., 2016), 
research generally suggests that individuals identified as CHR may have deficits in social 
cognition as their symptoms worsen (Green et al., 2011; Lee et al., 2015). Meaningful 
social exchanges typically require intact emotion processing (e.g., facial emotion 
identification), Theory of Mind (ToM), and social relationship perception; however, these 
areas of social cognition are typically impaired across the schizophrenia spectrum with 
deficits that may begin in the at-risk period (Green et al., 2011; Lee et al., 2015; 
Thompson et al., 2012). These areas of social cognition require the ability to differentiate 
emotions from the self and others. More specifically, ToM and social relationship 
perception also involve the capability to make inferences about other’s current feelings or 
future behaviors. This emotional attribution process is key for appropriate social 
functioning (Glenthøj et al., 2016). Accordingly, research shows that CHR individuals 
tend to have worse social skills when they exhibit poor social cognition (Glenthøj et al., 
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2016). Because stigma has been conceptualized as a social cognitive process (Corrigan & 
Watson, 2002; Cunningham & Luksted, 2017), it is conceivable that labeling and 
symptom stigma may also have important implications for social cognitive performance 
due to repeated stigma exposure and the potential for increased preoccupation with 
anticipated rejection, thus potentially increasing cognitive load.  
The literature examining the relationship between stigma and social cognition is 
scarce and to date, there is only one study that has investigated this association directly 
(Larsen et al., 2019). Prior work has shown that individuals identified as CHR who 
experience shame due to their psychosis-risk symptoms (i.e., symptom stigma) tend to 
have worse facial emotion recognition abilities. More specifically, these individuals 
exhibit poorer accuracy when identifying fearful facial expressions and increased 
misattribution of fear in non-fearful faces (Larsen et al., 2019). Based on prior evidence 
of an association between increased stigma and poorer facial emotion recognition (Larsen 
et al., 2019) and because ToM and social relationship perception abilities require the 
capacity to differentiate between the mental states of the self and others (Green et al., 
2011), there may also be a connection between ToM and social relationship perception 
accuracy and experiences of stigma.   
The aim of this research study is to explore the relationship between ToM, social 
relationship perception and stigma from a subset of a large dataset that includes 
individuals identified and labeled as CHR. Due to the paucity of research on the 
association between social cognition and stigma, the aims and hypotheses of this study 
are largely based on prior stigma work (Link et al., 1989; Link et al., 2015) that does not 
specifically include CHR samples. Our overarching question guiding this research study 
is:  What is the relationship between stigma and social cognition in CHR? 
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In order to answer the above question, we recognize that two divergent pathways 
may exist.  
1. CHR individuals who exhibit higher stigma may tend to demonstrate worse 
social cognitive performance due to increased stigma exposure in the community 
coupled with increased cognitive load from anticipated rejection. 
2. CHR individuals who exhibit higher stigma may tend to demonstrate better 
social cognition, which is based on the supposition that it might be necessary that 
individuals have some level of intact social cognition in order to correctly 
perceive stigmatizing interactions in general.  
According to symbolic interaction stigma (Link et al., 2015), both scenarios are 
plausible. CHR individuals may be subject to more encounters of stigma in the 
community due to expression of symptoms. Furthermore, this increased experience of 
stigma coupled with increased preoccupation of anticipated rejection may negatively 
impact social cognitive performance due to cognitive load difficulties. Alternatively, 
CHR individuals may experience more stigma in the community; however, their 
increased preoccupation with anticipated rejection may enhance social cognitive 
performance due to repetitive social rehearsal that could lead to improved social learning 
(Link et al., 2015).  
Drawing from prior literature (Larsen et al., 2019), we expect that symptom 
stigma (e.g., shame due to mental health symptoms) may be related to ToM and social 
relationship perception performance; however, labeling stigma will also be examined. 
This study also assessed if being labeled with a psychotic or non-psychotic risk status 
(e.g., risk for anxiety or depression vs. psychosis-risk) had a differential impact on self-
view. Because psychosis-related conditions are among the most highly stigmatized 
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mental health conditions (Room et al., 2001), a “most impacted” variable was measured 
in order to capture if being labeled as CHR was salient to individuals participating in the 
early identification and intervention process. This information is particularly useful to 
help elucidate potential mechanisms specific to at-risk stigma and the labeling process 
and may help inform early intervention tactics aimed at reducing the effect of stigma 
stress in the future. Due to how novel this at-risk designation is and the lack of 
understanding surrounding the impacts of a psychosis-risk label, thoughtful approaches to 
conceptualizing stigma-related risk diagnoses are imperative. Therefore, including a 
“most impacted” status variable is highly valuable to help distinguish any potential 
differential impacts of stigma processes. In order to operationalize this response, CHR 
individuals were asked to indicate which risk status (i.e., psychosis-risk or non-psychosis-
risk) had the biggest impact on how they viewed themselves as part of the larger stigma 
interview. This approach aims to elicit and distinguish between the levels of stigma held 
regarding psychosis-related and non-psychosis-related labeling processes and helps to 
better elucidate potential differences between diagnostic-specific stigma. With this in 
mind, our research questions are:  
1. How does ToM and social relationship perception relate to symptom and 
labeling stigma?  
2. What is the relationship between ToM, social relationship perception, labeling 
and symptom stigma and social functioning?  
3. What is the relationship between ToM, social relationship perception, labeling 
and symptom stigma and social functioning based on “most impacted” status?  
Because of an abundance of literature demonstrating that psychosis-related 
disorders tend to be associated with increased levels of stigma (Jenkins & Carpenter-
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Song, 2008; Lien et al., 2015; Yang et al., 2013), we expect that the endorsement of a 
psychosis-risk status as having a higher impact on self-view through the “most impacted” 
variable may be associated with higher levels of stigma than non-psychotic risk 
endorsement. Thus, a psychosis-risk “most impacted” status may moderate the 
relationship between social cognition and stigma. Overall, we aim to compare a 
mediation model (figure 1) to a moderated-mediation model (figure 2) where symptom 
and labeling-related stigma serve as a mediator between social cognition and social 









































173 CHR participants were recruited between November 2012 and December 
2015 as part of a multi-site study at Beth Israel Deaconess Medical Center/Harvard 
Medical School, Maine Medical Center, and New York State Psychiatric Institute. CHR 
individuals were self-referred in response to media, online advertisements and public 
transportation or recruited by outreach efforts conducted per site. Participants were told 
that they would be compensated $50 for study completion. Inclusion criteria were: 1) age 
12-35 years old; 2) met criteria for one or more of three CHR syndromes as per the SIPS 
(Miller et al., 2003); 3) capacity to give informed consent or assent. Exclusion criteria 
included: 1) past or present history of a psychotic disorder; 2) risk of harm to self or 
others; 3) major medical or neurological disorder; 4) IQ<70.  
 Written informed consent was provided by adult participants while minors gave 
written assent with parental/guardian written informed consent. All consent forms 
described potential CHR symptoms; however, the New York site specifically indicated 
that participants were at “a somewhat increased risk of psychosis.” This study received 
approval from all corresponding sites’ IRBs and all participants were given referrals to 
mental health treatment if not already receiving services.  
Study Procedures 
This study is part of a larger study that took approximately four to five hours to 
complete. Participants were given the option to break up the interview into smaller 
sessions and were given opportunities to rest as needed. CHR individuals were 
compensated once all study measures were complete. Although site clinicians were not 
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instructed to give uniform psychosis-risk feedback, they provided information to 
participants on their level of psychosis-risk based on standard practice with this 
population. Variations in feedback are common across CHR clinics and research settings 
and are based on clinical judgment that takes into account individual factors such as 
presenting concerns and questions, symptom severity, insight, language capacity, cultural 
values and norms. CHR individuals were told that their attenuated psychotic symptoms 
may worsen and that they were at a higher risk of developing psychosis as compared to 
their peers. Additionally, CHR individuals were informed that being at-risk is different 
than actually having a psychotic disorder.  
CHR symptoms and functioning were assessed through clinician interview while 
all other measures were assessed by self-report or via interview with a BA-level research 
assistant specifically trained in administering these assessments. The interview took place 
at each study site’s medical campus in a private room reserved for the study. Licensed 
clinicians were available for CHR participants during the interviews in the event of 
psychological distress.  
Measures  
Stigma Interview. The stigma interview was developed based on the Modified 
Labeling Theory (Link et al., 1989). Participants were asked about their perceptions of 
being at-risk for five conditions: “depression,” “anxiety,” “bipolar,” “psychosis,” and 
“schizophrenia.” CHR individuals were then asked which condition had the biggest 
impact on how they think of themselves. With this self-identified condition in mind, they 
were asked to answer specific stigma-related questions pertaining to both the label and 
symptoms of the condition including concepts of stereotype awareness, which refers to 
the awareness of negative and positive stereotypes about people with mental illness 
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(labeling: α=.70), stereotype agreement, which encapsulates how much the participant 
agrees with stereotypes regarding mental illness (labeling: α=.68), positive (labeling: 
α=.84; symptoms: α=.65) and negative emotions, such as relief and shame associated 
with experiencing symptoms or the labeling process (labeling: α=.60; symptoms: α=.74), 
secrecy, which refers to the attempt to conceal details about their mental illness (labeling: 
α=.60; symptoms: α=.63), experienced discrimination, which includes being treated 
differently by others due to their mental health problems (labeling: α=.84), and 
experienced support (Yang et al., 2015). 
Social Cognition Measures. Social relationship perception was assessed by the 
Relationships Across Domains (RAD-15; Sergi et al., 2009) questionnaire. The RAD-15 
aims to assess the ability to understand social relationships and make inferences about 
future behavior based on 15 vignettes given about a male-female dyad. The content of 
vignettes is based on relational models theory, which asserts that social behavior is 
governed by four relational models (communal sharing, authority ranking, market pricing 
and equality matching) across domains of social life (e.g., social decision-making, moral 
judgment, material transactions, etc.; Green et al., 2011). Participants were asked to use 
the information presented about each dyad to determine whether behaviors described in 
three statements are likely to occur or not by indicating “yes” or “no.” The RAD-15 
contains a total of 45 items and performance was calculated based on the total number of 
correct responses. The RAD-15 has been validated for schizophrenia and has good 
internal consistency, good group separation and has been shown to have associations to 
functioning (Green et al., 2011).  
Theory of Mind was assessed by The Awareness of Social Inference Test 
(TASIT; McDonald et al., 2006). The TASIT provides information about difficulties with 
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interpreting complex social phenomena in clinical populations. The TASIT consists of 16 
video-taped scenes meant to assess emotion recognition, the ability to interpret literal 
(sincerity and lies) and non-literal (sarcasm) conversational remarks and the ability to 
make judgments about the speakers’ thoughts, feelings, and intentions. Participants were 
presented with a video-taped vignette, each lasting anywhere from 15-60 seconds, and 
then asked to answer 4 forced-choice (yes/no) questions. Performance was determined by 
total correct responses and ranged from 0 to 64. The task has been shown to have good 
psychometric properties when used as a clinical test of social perception and is reliable 
for repeat administration (McDonald et al., 2006). Studies have also shown adequate 
group discrimination between chronic schizophrenia and controls using the TASIT 
(Green et al., 2011).  
CHR Symptoms. The Structured Interview for Psychosis-Risk Syndromes (SIPS; 
Miller et al., 2003; McGlashan, Walsh, & Woods, 2010c) was used to assess positive 
(five items), negative (six items), disorganized (four items) and general (four items) 
symptoms. Each symptom was rated on a scale from 0 to 6, with a 6 indicating full-blown 
psychosis. The attenuated range includes scores between 3 and 5. Participants must have 
scored at least a 3 on any symptom subscale but not exceed a score of 5 to be considered 
CHR (Miller et al., 2003).  
Comorbid Diagnoses. The Structured Clinical Interview for DSM-IV Axis-I 
Disorders, Patient Edition (SCID-I/P; First et al., 2002) was administered to assess 
comorbid diagnoses present in CHR participants. This was completed through clinician 
interview at each study site.  
Social Functioning. The Global Functioning: Social Scale (Cornblatt et al., 2007) 
was used to capture participants’ social involvement with peers, intimate partners, and 
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relatives. This scale assesses current level, lowest level and highest level of functioning 
in the past year ranging from 1 (poor functioning) to 10 (superior functioning).  
IQ. The Wechsler Abbreviated Scale of Intelligence (WASI; Saklofske, Caravan 
& Schwartz, 2000) was used to assess IQ. The Vocabulary and Matrix Reasoning 
subtests were used to calculate total IQ, and CHR Individuals must have scored at least a 






















We first obtained descriptive statistics and visually inspected both univariate and 
bivariate relationships for our variables of interest (demographics, labeling and symptom 
stigma subscales, TASIT, RAD-15, “most impacted” status variable, and social 
functioning scores). Only complete cases were examined. We then underwent the 
following analyses to answer our research questions, which are detailed below:   
1. How does ToM and social relationship perception relate to symptom and 
labeling stigma?  
a. We performed Pearson Correlations between ToM (TASIT), social 
relationship perception (RAD-15), labeling and symptom stigma 
subscales (stereotype awareness, stereotype agreement, positive 
emotions, negative emotions [shame], secrecy, experienced 
discrimination, experienced support). 
2. What is the relationship between ToM, social relationship perception, labeling 
and symptom stigma and social functioning?  
a. We performed a mediation analysis using the “mediate” package 
(Kosuke et al., 2010) in R Software (R Core Team, 2019). Models 
were entered based on Figure 1 by first assessing if there was a 
significant relationship between social cognition and social 
functioning. Once the main effect was examined, we analyzed the 
indirect effect of the mediator (labeling and symptom stigma) on the 
main effect.  
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3. What is the relationship between ToM, social relationship perception, labeling 
and symptom stigma and social functioning based on “most impacted” status? 
a. We performed a moderated-mediation analysis (Figure 2) using Hayes 
PROCESS Macro (Version 3.5.3; Hayes, 2017) for SPSS Statistics 
(Version 27; IBM Corp, 2017). We examined any main effects, 
followed by any interaction effects first. We examined the indirect 
effect of the mediator (labeling and symptom stigma) on the main 
effect while considering the moderator (“most impacted” status). 
Hayes’ model 7 was used for analysis.  
Covariates, including age, gender, race and ethnicity, and mother’s highest level 
of education, which served as a proxy for socio-economic status, were entered into both 
















Sample Characteristics  
 The sample was primarily young (M=18.64, SD=4.278), white (66%) and male 
(>65%). The majority of participants were unemployed students; however, almost 1/3 of 
subjects currently held some type of employment at the time of interview. Almost half of 
CHR participants were still in high school (48.2%) while just over 1/3 of subjects 
completed high school as their highest educational status. Most were single and never 
married. The majority of CHR participants’ mothers completed high school or went on to 
pursue higher education through college or graduate school. Almost half of participants 
were from Massachusetts (Harvard site, 47.9%), followed by Maine (31.9%) and New 
York City (Columbia site, 20.2%).  
 In terms of clinical symptoms (Table 2), just under half of CHR individuals were 
diagnosed with a comorbid depressive disorder, approximately 42% had an anxiety 
disorder, and less than 10% were diagnosed with a bipolar disorder. Additionally, most 
individuals did not endorse a psychosis-risk “most impacted” status. Overall, CHR 
individuals tended to perform well on both the TASIT and RAD-15, which is to be 
expected based on research that shows that CHR individuals perform intermediately 
between healthy controls and first episode psychosis populations on social cognitive tasks 










Participants (n=173*)  
  *n<173 indicates missing data 
N (%), M (SD) 
Gender (Male) (n=167) 109 (65.3%) 
Age (n=168) 18.65 (4.28) 
Site (total recruitment) 
  Harvard 
  Maine 






  First Nations 
  Asian 
  Black 
  White 
  Interracial 









  Hispanic 
 
22 (13.3%) 
Marital Status (n=166) 




  Full-time 
  Part-time 





Enrolled in School (n=163) 
  Yes 
 
127 (77.9%) 
Highest Education (n=164) 
  Grade School 
  High School 
  College 
  Graduate School 







Mother’ Highest Education (n=161) 
  No Schooling 
  Some High School 
  High School 
  Some College or Technical School 
  College or Technical School 















Participants (n=173*)  
  *n<173 indicates missing data 
Participants 
N (%), M (SD) 
Stigma Subscales Labeling, Symptom 
  Stereotype Awareness (n=150) 43.65 (6.81) 
  Stereotype Agreement (n=151) 19.16 (3.87) 
  Negative Emotions (Shame) (n=150) 6.39 (2.47), 6.94 (2.45) 
  Positive Emotions (n=150) 8.79 (3.01), 7.10 (2.89) 
  Secrecy (n=150) 2.24 (1.62), 1.62 (1.14) 
  Experienced Discrimination (n=148) 9.76 (4.79), 9.90 (4.81) 
  Experienced Support (n=150) 3.22 (1.18), 3.02 (1.18) 
Most Impacted Status (n=152)  
  Psychosis-Risk 43 (28.3%) 
SIPS Score  
  Positive (n=166) 
  Negative (n=157)   
  Disorganized (n=156) 





Comorbid Diagnoses (n=166) 
  Depression 
  Anxiety 





TASIT (n=140) 52.67 (6.45) 
RAD-15 (n=134) 32.74 (4.80) 




 Pearson correlations were performed between stigma subscales and social 
cognition tasks in order to delineate bivariate associations (Table 2). The TASIT total 
score was significantly associated with labeling secrecy (r=-0.202, p<0.05) and 
experienced discrimination (r=-0.205, p<0.05). The TASIT total score was also 
negatively associated with positive emotions related to symptoms (r=-0.211, p<0.05).  
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The RAD-15 total score was positively associated with stereotype agreement (r=0.242, 
p<0.01) and negatively associated with positive emotions related to symptoms (r=-0.214, 
p<0.05). Additionally, TASIT and RAD-15 total scores were highly positively associated 






Social Cognition Task Stigma Subscale P value r 




 Positive Emotions** 0.023 -0.211 




 Positive Emotions** 0.021 -0.214 
 TASIT <.001 0.467 




These results indicate that increased ToM accuracy was associated with decreased 
labeling secrecy, decreased experiences of labeling-related discrimination and less 
positive emotions about their symptoms. Additionally, these findings demonstrate that 
CHR individuals who scored higher on the RAD-15 had fewer positive emotions about 
their symptoms and tended to have higher levels of stereotype agreement about their label 
as compared to those with lower RAD-15 scores. As presented in Table 2, the TASIT and 
RAD-15 total scores were highly correlated with one another.  
Mediation Analysis 
 No significant effects were found when the RAD-15 total score was included in 
the model; however, several significant findings were observed when the TASIT total 
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score was incorporated. Due to the nature of multi-site data, clustering effects were also 
examined by computing an intraclass correlation (ICC) for all relevant variables. All 
ICCs were zero or near zero, which indicates that clustering by site was not likely present 
for the variables of interest. Data was also visually inspected by site to further determine 
if there were any clustering effects apparent.   
Labeling Secrecy 
The Baron & Kenny (1986) method of mediation analysis was utilized, and data 
was run in R Software (R Core Team, 2019) with the “mediate” package (Kosuke et al., 
2010). The effect of ToM on social functioning was fully mediated by secrecy associated 
with labeling. As Figure 3 depicts, the regression coefficient between the TASIT total 
score and social functioning (p=0.032) and the regression coefficient between labeling 
secrecy and social functioning (p=0.005) was significant. The indirect effect was (-0.064) 
* (-0.039) = 0.002. Bootstrapping procedures were performed to test the significance of 
the indirect effect. Unstandardized indirect effects were calculated for each of the 1,000 
bootstrapped samples and a 95% confidence interval was computed by determining the 
indirect effects at the 2.5th and 97.5th percentiles. The bootstrapped unstandardized 
indirect effect was 0.002 with a 95% confidence interval ranging from 0.0007 and 0.020. 
Therefore, the indirect effect was statistically significant (p<0.05). The model presented 
below (Figure 3) includes all covariates (gender, race and ethnicity, and mother’s highest 
















The Baron & Kenny (1986) method of mediation was used for analysis in R 
Software (R Core Team, 2019) with the “mediate” package (Kosuke et al., 2010). The 
effect of ToM on social functioning was fully mediated by experienced discrimination 
associated with symptoms. As Figure 4 demonstrates, the regression coefficient between 
the TASIT total score and social functioning showed trend significance (p=0.055). Trend 
significance levels were accepted for further analysis in order to delineate potential 
mediators in this relatively small sample for analysis. The regression coefficient between 
symptom discrimination and social functioning (p=0.003) was significant. The indirect 
effect was (-0.152) * (-0.014) = 0.002. Bootstrapping procedures were performed to test 
the significance of the indirect effect. Unstandardized indirect effects were calculated for 
each of the 1,000 bootstrapped samples and a 95% confidence interval was computed by 
determining the indirect effects at the 2.5th and 97.5th percentiles. The bootstrapped 
unstandardized indirect effect was 0.002 with a 95% confidence interval ranging from 
0.0005 and 0.020. Therefore, the indirect effect was statistically significant (p<0.05). The 
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model presented below (Figure 4) includes all covariates (gender, race and ethnicity, and 
mother’s highest level of education). 
 
Figure 4 








Moderated Mediation Analysis 
 Hayes PROCESS Macro (Version 3.5.3; Hayes, 2017) for SPSS Statistics 
(Version 27; IBM Corp, 2017) was utilized to analyze the proposed moderated-mediation 
model (Figure 2). The outcome variable (Y) was included as current Social Functioning 
score, the predictor variable (Y) was incorporated as ToM and RAD-15 accuracy 
separately, the mediator (M) was entered as labeling and stigma variables and the 
moderator (W) was comprised of the “most impacted” variable. For this analysis, the 
“most impacted” variable was reduced from a 5-factor categorical variable to a 2-factor 
binary variable in order to address our specific research question associated with 
psychosis-related risk and to prevent unequal groups. The binary variable was entered as 
non-psychotic (i.e., depression, anxiety and bipolar-risk) vs. psychosis-risk (i.e., 
psychosis and schizophrenia) “most impacted” status to determine if a moderating effect 
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was present. Appropriate variables were mean centered before analysis to prevent 
multicollinearity. ICCs were computed for all relevant variables. All ICCs were zero or 
near zero, indicating that clustering by site was not present for the variables of interest. 
 When the RAD-15 total score was entered into the model, no significant effects 
were found; however, when the TASIT total score was included, findings were 
significant.  
Labeling Discrimination 
There was a significant negative effect (-.238) of ToM on experienced 
discrimination due to labeling (p<.01). Additionally, a significant interaction was 
observed when considering “most impacted” status whereby the “most impacted” 
variable moderated the relationship between ToM and labeling discrimination (Figure 5; 
p<.05).  There was a significant negative main effect of the mediator (experienced 
discrimination due to labeling) on current social functioning (p<.05) while a positive 
trend main effect between ToM and current social functioning scores (p=.066) was found. 
Tests of the indirect effect at -1 SD and 1 SD of the moderating variable were performed 
with a 95% bias corrected confidence interval and 5,000 bootstrapped samples. The 
indirect effects of ToM on current Social Functioning at psychotic vs. non-psychotic 
“most impacted” status varied. Significant effects were found when impact status 
included individuals who endorsed non-psychosis-risk (p<.05 with LLCI = 0.003 and 
ULCI = 0.041). Non-significant effects were observed when considering psychosis-risk 
impact status (p>.05 with LLCI=-0.29 and ULCI = 0.007). The Index of Moderated  
Mediation for “most impacted” status had an unstandardized coefficient of -0.031 with a 
LLCI = -0.060 and ULCI = -0.001, which indicates that the overall moderated-mediation 
model was supported and is depicted below (Figure 6). 
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Figure 5 










When considering the two divergent proposed pathways, Pathway 1 seems 
plausible due to the majority of negative relationships observed between social cognition 
and stigma. Pathway 1 anticipated that CHR individuals would exhibit higher stigma 
coupled with worse social cognitive performance. Interestingly, ToM was the only 
significant marker of social cognitive performance when considering this negative 
relationship with the exception of positive emotions due to symptoms, which was also 
related to social relationship perception. More specifically, ToM accuracy was associated 
with less labeling secrecy and decreased experienced discrimination due to labeling. 
Although ToM and social relationship perception were each differentially related to 
stigma, they were highly correlated with one another. This finding suggests that although 
these constructs are related to the broader characterization of social cognition, they may 
vary in their specific relationships with stigma and indicates that distinctive processes 
might occur.  
When mediation and moderated-mediation models were tested, only ToM was a 
significant predictor of current social functioning. Taken together, secrecy due to labeling 
and experienced discrimination due to symptoms both mediated the relationship between 
ToM and social functioning. In all scenarios, increased ToM performance was associated 
with better social functioning, which can be expected based on the idea that individuals 
may exhibit better social skills when their ToM is intact (Glenthøj et al., 2016). However, 
this positive association was mediated by decreased stigma (i.e., labeling secrecy and 
symptom discrimination). Converse to Pathway 1, this suggests that individuals who have 
higher ToM and better social functioning tend to have less stigma. More specifically, 
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these individuals tend to be less secretive about their label and experience less 
discrimination due to their symptoms. This finding aligns with the concept of stigma 
resistance whereby stigmatized individuals may consciously reject being devalued and 
discriminated against as mental health consumers (Thoits & Link, 2015). They are able to 
refute negative stereotypes ascribed to their mental health status through acts of 
challenging, which refers to being in opposition of other people’s negative perceptions 
and unjust actions toward individuals with mental illness, and deflecting, which consists 
of conceptualizing others’ maltreatment as not applicable and irrelevant to the self 
(Thoits & Link, 2015).  
 Information pertaining to ways to promote stigma resistance is crucial for early 
intervention programs, such as those for CHR populations. For individuals seeking 
preventative treatment from psychosis-risk clinics, there is a heightened potential to 
experience the pervasive effects of stigma on self-identity, which can have lasting effects 
on real-world outcomes, such as social functioning (Lysaker, Roe & Yanos, 2007). While 
the directionality can be interpreted based on those who exhibit stigma resistance, it can 
also be interpreted based on the opposing direction. Individuals with less intact ToM and 
decreased social functioning tend to exhibit more stigma. Therefore, the information 
extrapolated from the mediation model serves as a key clinical implication whereby 
clinicians may develop interventions that could potentially decrease stigma while 
simultaneously improving other outcomes, such as ToM and social functioning.  
While stigma interventions for serious mental illness, such as schizophrenia, exist 
(Tsang et al., 2016), to date, there is only one specifically designed for CHR and stigma, 
which is primarily a family-based psychoeducational intervention (McFarlane et al., 
2012). This dearth in direct clinical applicability could guide future development of 
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stigma interventions in CHR populations. Specifically, early intervention programs may 
consider incorporating ways to improve ToM and social functioning, which could also 
include integrating psychoeducational tools and more targeted evidence-based 
interventions, such as cognitive-behavioral strategies, that aim to decrease secrecy and 
the impact of discriminatory experiences associated with their label and symptoms in 
order to promote stigma resistance. It is especially important to consider that while 
improving social cognitive ability would be a positive outcome, this improvement could 
also be associated with decreased positive emotions about their CHR experiences. Both 
labeling and symptom-related stigma were negatively associated with ToM and social 
relationship perception, which indicates that individuals with intact social cognition tend 
to feel less positively about both their label and symptoms associated with their mental 
health problems. Therefore, it is crucial for specialized programs to consider this 
potential negative consequence on self-view through increasing social cognition accuracy 
by striking a well-informed, delicate balance in order to achieve improvements in both 
stigma and social cognitive domains. Additionally, although the results did not show a 
stark differentiation between symptom and labeling-related stigma, this specific 
delineation is still important to consider when tailoring clinical interventions in order to 
increase specificity and applicability to CHR populations.  
For bivariate associations, all significant stigma subscales (labeling secrecy, 
labeling discrimination and positive emotions about symptoms) exhibited negative 
directionality and similar magnitude, with the exception of stereotype agreement. A 
moderately positive correlation was found between stereotype agreement and social 
relationship perception accuracy, which indicates that CHR individuals who agree with 
stereotypes associated with their mental health label tend to be more accurate when 
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judging social relationships. This association could be present because of the suggestion 
included in Pathway 2, which incorporates the proposed idea that a certain level of intact 
social perception must be present in order to correctly perceive potentially stigmatizing 
interactions. Additionally, these individuals may also be more well-versed in interpreting 
social relationship scenarios due to increased social rehearsal stemming from higher 
stereotype agreement. CHR individuals who tend to exhibit more stereotype agreement 
may be more concerned with how others may perceive them in social interactions, which 
may influence their desired level of social mastery in order to conceal their stigmatized 
status. These individuals may also aspire to obtain more social relationship knowledge in 
an attempt to more accurately perform in social interactions, so their stigmatized status 
remains unknown. This is a possible outcome that stems from the idea that increased 
experiences of stigma could lead to increased preoccupation with social behavior and 
increased coping responses, as posited by symbolic interaction stigma and Modified 
Labeling Theory (Link et al., 1989; Link, Phelan & Yang, 2015).  
Moderated mediation analyses showed that the “most impacted’ status was 
established as a moderator for the model; however, significance was found for 
individuals who endorsed a non-psychotic risk status instead of a psychosis-risk status. 
Contrary to our hypothesis, this non-psychotic risk endorsement strengthened the 
negative relationship between ToM and experienced discrimination due to their label. 
This may have occurred for several reasons. Firstly, most CHR individuals also tend to 
experience comorbid mood disorders (Fusar-Poli et al., 2014; Salokangas et al., 2012). In 
a meta-analysis of 509 CHR individuals, researchers found that approximately 41% of 
individuals were diagnosed with a depressive disorder and 15% were diagnosed with an 
anxiety disorder (Fusar-Poli et al., 2014). This comorbidity was also demonstrated in our 
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sample where just under half of all CHR participants were also diagnosed with 
depression, approximately 42% were diagnosed with anxiety and almost 10% were 
diagnosed with a comorbid bipolar disorder. Therefore, CHR individuals could have 
experienced stigma related to being labeled with these diagnoses prior to their CHR 
designation, which may have influenced their “most impacted’ status endorsement.  
Secondly, because CHR individuals tend to initiate their first contact with a 
mental health provider due to symptoms unrelated to psychosis, this psychosis-risk label 
may not be the most impacted status by the time they are in specialized treatment. In a 
manuscript reported elsewhere (Li et al., in preparation) that documented the first 
concerning symptoms that brought this specific CHR sample into mental health 
treatment, only about 7% of individuals reported psychosis-related symptomatology. 
Interestingly, almost 40% of individuals indicated that their first concerning symptoms 
were affective in nature, such as anxiety, moodiness or trouble controlling emotions. This 
further bolsters the idea that non-psychosis-related symptoms may, in fact, be more 
salient to CHR individuals because it underscores their lived experience. Subthreshold 
psychotic symptoms may not be present enough to cause significant distress; however, 
experiencing clinical depression or anxiety on a daily basis may leave more lasting 
impressions on self-view due to the heightened prevalence of symptoms in everyday life.  
Finally, although this non-psychotic risk endorsement finding was surprising due 
to the insurmountable evidence that demonstrates psychosis as being one of the most 
highly stigmatized conditions (Room et al., 2001), it is also hopeful. Perhaps early 
interventions programs are adequately targeting the labeling-related effects of psychosis-
risk, which demonstrates a highly positive effect of specialized treatment in relation to 
stigma. Employing targeted resources to combat the deleterious effects of stigma for 
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psychosis-risk is highly important. Overall, these results indicate that individuals who 
endorse a psychosis-risk status as most impactful in how they view themselves do not 
tend to exhibit any more stigma than those who endorse a non-psychotic risk status. This 
implies that CHR clinics are particularly beneficial for individuals who may otherwise be 
stigmatized due to psychosis-related labeling and expression of symptoms. However, 
more nuanced ways to decrease stigma while increasing performance in key areas of 
functioning, such as social cognition and social functioning, are presented to help further 
improve and tailor specialized services.  
Limitations  
 Although these findings are highly clinically relevant and informative, several 
limitations exist. First, even though this sample of CHR individuals is considered large 
due to the difficulties often present in the recruitment of this population, it is relatively 
small for statistical analyses. Second, this analysis was done as part of a larger study that 
did not solely focus on social cognition and social functioning. Therefore, the number 
and specificity of assessments for these constructs was limited. Third, it was not 
determined when this sample had their first contact with mental health services, which 
could have influenced their individual experiences and trajectories of stigma. At the point 
of interview, CHR individuals could have had a varied timepoint from which they first 
began treatment, whether it was solely for psychosis-risk presentations or other comorbid 
conditions. Furthermore, this sample was primarily white and male. Therefore, results 
should be interpreted cautiously when applying them to culturally diverse populations.  
Future research should aim to address these limitations by attempting to recruit a 
larger sample that is highly powered to detect more significant effects, including a variety 
of well-established social cognition and social functioning assessments specifically 
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normed for CHR populations, and collecting information about initial contact with mental 
health providers. Additionally, because levels of stigmatization tend to vary cross-
culturally (Krendl & Pescosolido, 2020), it is also important to consider ways to 
incorporate culturally relevant adaptations of stigma into clinical interventions. 
Recruiting more diverse CHR samples is key to better understanding how other social 
disparities, such as race and sexual identity statuses, may further influence the overall 
impact of mental health stigma and experiences of discrimination. Addressing these 
limitations could further provide crucial information to specialized treatment programs, 
which could potentially have real-world implications that aim to reduce stigma stress, 
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